<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">russjcardiol</journal-id><journal-title-group><journal-title xml:lang="en">Russian Journal of Cardiology</journal-title><trans-title-group xml:lang="ru"><trans-title>Российский кардиологический журнал</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1560-4071</issn><issn pub-type="epub">2618-7620</issn><publisher><publisher-name>«SILICEA-POLIGRAF» LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.15829/1560-4071-2021-4028</article-id><article-id custom-type="elpub" pub-id-type="custom">russjcardiol-4028</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL ARTICLES</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ СТАТЬИ</subject></subj-group></article-categories><title-group><article-title>Cardiovascular system status of long-livers in Moscow: the prevalence of cardiovascular diseases and their risk factors</article-title><trans-title-group xml:lang="ru"><trans-title>Состояние сердечно-сосудистой системы сверхдолгожителей Москвы: распространённость сердечно-сосудистых заболеваний и их факторов риска</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-0048-268X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ерусланова</surname><given-names>К. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Eruslanova</surname><given-names>K. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Младший научный сотрудник лаборатории сердечно-сосудистого старения ОСП РГНКЦ.Москва.</p></bio><bio xml:lang="en"><p>Moscow.</p></bio><email xlink:type="simple">kae.07@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-1695-9107</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Лузина</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Luzina</surname><given-names>A. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Младший научный сотрудник лаборатории общей гериатрии и нейрогеритарии ОСП РГНКЦ.Москва.</p></bio><bio xml:lang="en"><p>Moscow.</p></bio><email xlink:type="simple">alexalav@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-0556-1697</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Онучина</surname><given-names>Ю. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Onuchina</surname><given-names>Yu. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Врач эндокринолог ОСП РГНКЦ.Москва.</p></bio><bio xml:lang="en"><p>Moscow.</p></bio><email xlink:type="simple">onuchina90@list.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-1222-3351</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Остапенко</surname><given-names>В. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Ostapenko</surname><given-names>V. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Кандидат медицинских наук, заведующий отделением гериатрической терапии ОСП РГНКЦ, ассистент кафедры болезней старения ФДПО.Москва.</p></bio><bio xml:lang="en"><p>Moscow.</p></bio><email xlink:type="simple">ostapenko_vs@rgnkc.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6465-4842</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Шарашкина</surname><given-names>Н. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Sharashkina</surname><given-names>N. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Кандидат медицинских наук, старший научный сотрудник лаборатории общей гериатрии и нейрогеритарии.Москва.</p></bio><bio xml:lang="en"><p>Moscow.</p></bio><email xlink:type="simple">sharashkina_nv@rgnkc.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-4497-1277</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Алимова</surname><given-names>Е. Р.</given-names></name><name name-style="western" xml:lang="en"><surname>Alimova</surname><given-names>E. R.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Студентка.Москва.</p></bio><bio xml:lang="en"><p>Moscow.</p></bio><email xlink:type="simple">atka22@rambler.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-0694-7062</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Акашева</surname><given-names>Д. У.</given-names></name><name name-style="western" xml:lang="en"><surname>Akasheva</surname><given-names>D. U.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Кандидат медицинских наук, ведущий научный сотрудник отдела фундаментальных и прикладных аспектов ожирения.Москва.</p></bio><bio xml:lang="en"><p>Moscow.</p></bio><email xlink:type="simple">dariga-akasheva@yandex.ru</email><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-5405-5459</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Базаева</surname><given-names>Е. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Bazaeva</surname><given-names>E. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Кандидат медицинских наук, научный сотрудник отдела нарушений сердечного ритма и проводимости.Москва.</p></bio><bio xml:lang="en"><p>Moscow.</p></bio><email xlink:type="simple">bazaeva_ev@mail.ru</email><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-7989-0760</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ершова</surname><given-names>А. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Ershova</surname><given-names>A. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Кандидат медицинских наук, руководитель лаборатории клиномики.Москва.</p></bio><bio xml:lang="en"><p>Moscow.</p></bio><email xlink:type="simple">alersh@mail.ru</email><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-4453-8430</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Драпкина</surname><given-names>О. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Drapkina</surname><given-names>O. M.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Доктор медицинских наук, член-корреспондент, профессор, директор.Москва.</p></bio><bio xml:lang="en"><p>Moscow.</p></bio><email xlink:type="simple">ODrapkina@gnicpm.ru</email><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-1628-5093</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Котовская</surname><given-names>Ю. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Kotovskaya</surname><given-names>Yu. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Доктор медицинских наук, профессор, заместитель директора по научной работе ОСП РГНКЦ.Москва.</p></bio><bio xml:lang="en"><p>Moscow.</p></bio><email xlink:type="simple">kotovskaya_yv@rgnkc.ru</email><xref ref-type="aff" rid="aff-4"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-5272-0454</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Рунихина</surname><given-names>Н. К.</given-names></name><name name-style="western" xml:lang="en"><surname>Runikhina</surname><given-names>N. K.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Профессор, заместитель директора по гериатрии ОСП РГНКЦ.Москва.</p></bio><bio xml:lang="en"><p>Moscow.</p></bio><email xlink:type="simple">nkrunihina@rgnkc.ru</email><xref ref-type="aff" rid="aff-4"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-4193-688X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ткачева</surname><given-names>О. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Tkacheva</surname><given-names>O. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Доктор медицинских наук, профессор, директор ОСП РГНКЦ.Москва.</p></bio><bio xml:lang="en"><p>Moscow.</p></bio><email xlink:type="simple">tkacheva@rgnkc.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>РНИМУ им. Н.И. Пирогова Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Pirogov Russian National Research Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>РНИМУ им. Н.И. Пирогова</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Pirogov Russian National Research Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru"><institution>Научно-медицинский исследовательский центр терапии и профилактической медицины Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>National Medical Research Center for Therapy and Preventive Medicine</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-4"><aff xml:lang="ru"><institution>РНИМУ им. Н.И. Пирогова Минздрава</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Pirogov Russian National Research Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2021</year></pub-date><pub-date pub-type="epub"><day>03</day><month>04</month><year>2021</year></pub-date><volume>26</volume><issue>1S</issue><fpage>4028</fpage><lpage>4028</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Eruslanova K.A., Luzina A.V., Onuchina Y.S., Ostapenko V.S., Sharashkina N.V., Alimova E.R., Akasheva D.U., Bazaeva E.V., Ershova A.I., Drapkina O.M., Kotovskaya Y.V., Runikhina N.K., Tkacheva O.N., 2021</copyright-statement><copyright-year>2021</copyright-year><copyright-holder xml:lang="ru">Ерусланова К.А., Лузина А.В., Онучина Ю.С., Остапенко В.С., Шарашкина Н.В., Алимова Е.Р., Акашева Д.У., Базаева Е.В., Ершова А.И., Драпкина О.М., Котовская Ю.В., Рунихина Н.К., Ткачева О.Н.</copyright-holder><copyright-holder xml:lang="en">Eruslanova K.A., Luzina A.V., Onuchina Y.S., Ostapenko V.S., Sharashkina N.V., Alimova E.R., Akasheva D.U., Bazaeva E.V., Ershova A.I., Drapkina O.M., Kotovskaya Y.V., Runikhina N.K., Tkacheva O.N.</copyright-holder><license license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://russjcardiol.elpub.ru/jour/article/view/4028">https://russjcardiol.elpub.ru/jour/article/view/4028</self-uri><abstract><p>Over the past century, an increase in life expectancy has been observed in Russia and in the world. According to the United Nations, by 2100, the number of centenarians worldwide will reach 25 million. Despite the annual increase in the number of super-centenarians, this age group remains poorly understood.Aim. To estimate the prevalence of cardiovascular diseases (CVD) and the main risk factors among super-centenarians in Moscow.Material and methods. According to the register of long-livers in Moscow, 82 people aged 95 to 105 were included. Participants were examined at home.The history of life and the presence of chronic diseases was collected by participant words. To assess the state of cardiovascular system, an ultrasound of the heart and main arteries was performed.Results. Conventional CVD risk factors were the exception rather than the rule among study participants (smoking — 8 patients (9,8%), alcohol abuse — 4 (4,9%), obesity — 6 (7,3%)). Dyslipidemia was relatively widespread (n=37; 45,1%), however, there were no pronounced abnormalities in the lipid profile: the maximum increase in low-density lipoproteins was 5,6 mmol/L. The most common CVDs among the participants were hypertension (n=64; 78%), coronary artery disease (n=42; 51,2%), and heart failure (n=26; 31,7%); other diseases were much less common. The most common echocardiographic changes were left atrial dilatation (n=38; 74,5%), increased left ventricular mass, thickening of left ventricular posterior wall (n=24; 48%) and interventricular septum (n=51; 100%). Diastolic and systolic heart failure were not widespread among long-livers: 16 (32%) and 2 (3,9%), respectively. Despite a rather large number of atherosclerotic plaques in the common carotid and femoral arteries, the number of hemodynamically significant plaques was low (n=3; 4,6%). An intima-media thickening up to 1,0-1,1 mm was found.Conclusion. Long-livers in Moscow are characterized by a low prevalence of traditional CVD risk factors (with the exception of hypertension) and a fairly high prevalence of atherosclerotic CVDs, which are characterized by a subclinical course.</p></abstract><trans-abstract xml:lang="ru"><p>На протяжении последнего века в России и в мире наблюдается увеличение продолжительности жизни. Согласно данным Организации Объединенных Наций к 2100г число столетних граждан по всему миру достигнет 25 млн человек. Несмотря на ежегодное увеличение числа супер-долгожителей, данная возрастная группа остается мало изучена.Цель. Оценить распространённость сердечно-сосудистых заболеваний (ССЗ) и основных факторов риска (ФР) среди супер-долгожителей Москвы.</p><p>Материал и методы. По данным регистра сверхдолгожителей Москвы было набрано 82 человека в возрасте от 95 до 105 лет. Участники осматривались на дому. Анамнез жизни и наличие хронических заболеваний собирался со слов участников исследования. Для оценки состояния сердечно-сосудистой системы было выполнено ультразвуковое исследование сердца и магистральных артерий.Результаты. Классические ФР развития ССЗ были скорее исключением, чем правилом среди участников исследования (курение 8 (9,8%), злоупотребление алкоголем 4 (4,9%), ожирение 6 (7,3%)). Дислипидемия была относительно широко распространена (37 (45,1%)), однако выраженных нарушений липидного профиля выявлено не было, максимальное повышение липопротеинов низкой плотности составило 5,6 ммоль/л. Наиболее часто встречаемыми ССЗ среди участников исследования были гипертоническая болезнь (64 (78%)), ишемическая болезнь сердца (42 (51,2%)) и хроническая сердечная недостаточность (26 (31,7%)); другие заболевания встречались значительно реже. Наиболее часто встречаемыми изменениями по данным эхокардиографии были расширение левого предсердия (38 (74,5%)), увеличение массы миокарда левого желудочка, утолщения задней стенки левого желудочка (24 (48%)) и межжелудочковой перегородки (51 (100%)). Диастолическая и систолическая сердечная недостаточность не были широко распространены среди долгожителей, 16 (32%) и 2 (3,9%), соответственно. Несмотря на довольно большое число атеросклеротических бляшек в бассейне общих сонных и бедренных артерий (5), количество гемодинамически значимых было минимально (3 (4,6%)). Было обнаружено утолщение толщины интима-медиа до 1,01,1 мм.Заключение. Для долгожителей Москвы характерна низкая распространенность традиционных ФР ССЗ (за исключением артериальной гипертонии) и достаточно высокая распространенность атеросклеротических ССЗ, для которых характерно субклиническое течение.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>долгожители</kwd><kwd>факторы риска</kwd><kwd>курение</kwd><kwd>толщина интима-медиа</kwd><kwd>артериальная гипертония</kwd><kwd>дислипидемия</kwd></kwd-group><kwd-group xml:lang="en"><kwd>long-livers</kwd><kwd>risk factors</kwd><kwd>smoking</kwd><kwd>intima-media thickness</kwd><kwd>hypertension</kwd><kwd>dyslipidemia</kwd></kwd-group></article-meta></front><body><p>Over the past century, there has been an increase in life expectancy: from 1950 to 2017, the mean life expectancy increased from 48,1 to 70,5 years for men and from 52,9 to 75,6 years for women [<xref ref-type="bibr" rid="cit1">1</xref>]. At the same time, the number of long-livers and centenarians is increasing: people who have reached the age of 85 and 100 years, respectively. According to calculations of the United Nations (UN) by 2100, the number of centenarians worldwide will reach 25 million people [<xref ref-type="bibr" rid="cit2">2</xref>].</p><p>In Russia, the same trends are observed: the annual growth of long-livers since 2014 is 600-900 people per year, and by 2019, 20582 centenarians (5895 men and 14687 women) live in the country [<xref ref-type="bibr" rid="cit3">3</xref>].</p><p>Cardiovascular diseases (CVDs) have been the leading cause of death for people 65 years of age and older in Russia and in the world for at least the last 20 years. Despite the increase in the number of centenarians, to date, the state of cardiovascular system and the main cardiovascular risk factors (RF) have been little studied in this age group.</p><p>The aim was to assess the state of cardiovascular system, the prevalence of CVDs and related main risk factors (RFs) among centenarians.</p><sec><title>Material and methods</title><p>The study protocol was approved by the independent ethics committee of the Pirogov Russian National Research Medical University, Russian Clinical and Research Center of Gerontology (meeting № 02/15 dated February 12, 2015). This study is registered with ClinicalTrials.gov № NCT02876809. The study recruitment was initiated in 2015: 82 residents of Moscow aged 95 and older were included, who personally (if impossible, with the help of relatives or guardians) agreed to undergo the examination. Fifty-one participants underwent echocardiography, while 64 — laboratory examination, including biochemical analysis and complete blood count.</p><p>The inclusion criterion was age 95 and older. There were no exclusion criteria, with the exception of refusal to participate in the study.</p><p>Patients were seen at home in the presence of a social worker and/or the patient’s relatives.</p><p>History was collected by patient’s and/or his relatives’ account. To identify chronic diseases and analyze the therapy taken, when possible, data from available medical records were used.</p><p>We collected data on weight and height and then calculated the body mass index (BMI). BMI &lt;18,5 kg/m2 was considered as underweight, from 18,5 to 24,9 kg/m2 — normal body weight, from 25 to 29,9 kg/m2 — overweight, and 30 or more kg/m2 — obesity [<xref ref-type="bibr" rid="cit4">4</xref>].</p><p>The study of the lipid profile and glycated hemoglobin levels was carried out using an AU 680 (Beckman Coulter) clinical chemistry system.</p><p>There were following reference values for lipid profile parameters: &lt;5,0 mmol/L for total cholesterol (TC), 3,5 mmol/L for low density lipoproteins (LDL) and &lt;1,7 mmol/L for triglycerides (TG). For men, the level of high-density lipoproteins (HDL) was considered low at &lt;1,2 mmol/L, and for women — 1,0 mmol/L [<xref ref-type="bibr" rid="cit5">5</xref>].</p><p>Ultrasound of the heart and main arteries was performed using a Samsung Medison U6 portable ultrasound machine. Cardiac structure and function was assessed using the normal ranges from 2012 Russian Society of Cardiology guidelines [<xref ref-type="bibr" rid="cit6">6</xref>]. Vascular stiffness was determined using SphygmaCor technology (AtCor, Sydney, Australia).</p><p>Statistical data processing was performed using the SPSS 23.0 program (SPSS Inc., USA). Due to the small number of observations, the analysis of quantitative traits’ distribution was not carried out. Quantitative variables are presented as Me (25%; 75%), where Me is the median, 25% — 25th percentile, 75% — 75th percentile, since the data is not normally distributed.</p></sec><sec><title>Results</title><p>The mean age was 98,3 (95-105) years, of which 72 (87,8%) were women. At the same time, the age of 66 participants in the study was from 95 to 99 years old and 16 was 100 years old or more.</p><p>Risk factors. The majority of long-livers never smoked (n=73; 89%), while 8 (9,8%) participants were former smokers, and one (1,2%) continued to smoke (up to 5 cigarettes a day). The median duration of smoking among smokers was 5 years (range 1 to 65 years).</p><p>Alcohol consumption was not widespread among long-livers: 78 people (95,1%) drank alcohol-containing products 2-3 times a year (up to 2 glasses per meal), and 4 (4,9%) drank alcohol regularly.</p><p>For the most part, centenarians led a sedentary lifestyle (56 (68,3%)). The minority regularly went for walks (18 (22%)) or did morning exercises (7 (8,5%)). Of these 25 people (30,5%), 16 (19,5%) spent up to 30 minutes a day on sports, 4 (4,9%) — up to 1 hour, and the remaining 5 (6,1%) — more than an hour.</p><p>Obesity and overweight were in 6 (7,3%) and 28 (34,1%) study participants, respectively.</p><p>Thus, the classic RFs for CVD were the exception rather than the rule among participants (Figure 1).</p><fig id="fig-1"/><p>CVD. The most common diseases among the study participants were hypertension (64 (78%)), coronary artery disease (CAD) (42 (51,2%)) and heart failure (HF) (26 (31,7%)). Acute myocardial infarction (MI) or stroke were significantly less common — in 16 (19,5%) and 17 (20,7%) participants. Occlusive peripheral arterial disease and atrial fibrillation were extremely rare: (3 (3,7%)) and (7 (8,5%)), respectively (Figure 2).</p><fig id="fig-2"/><p>Therapy. One of the most widespread drugs among long-livers was acetylsalicylic acid as primary (20 (24,4%) and secondary prevention of CVD (14 (17,1%)).</p><p>The most frequently prescribed antihypertensive therapy were angiotensin-converting enzyme inhibitors (25 (30,5%)) and beta-blockers (22 (26,8%)). Significantly less frequently, patients took angiotensin II receptor blockers (13 (15,9%)) and calcium channel blockers (16 (19,5%)).</p><p>Slightly less than a quarter (17 (20,7%)) received diuretic therapy (thiazide and loop diuretics). Five (5,6%) subjects took long-acting nitrates. None of the patients with atrial fibrillation took anticoagulants (Table 1).</p><p>Table 1</p><p>Medicines taken by study participants (n=82)</p><p>Abbreviation: ACE — angiotensin converting enzyme.</p><p>Cardiac ultrasound. Echocardiography was performed in 51 study participants. There were following echocardiographic findings: left atrium (LA) dilation (74,5%), interventricular septum thickening &gt;1,1 cm (100%), increased pulmonary artery pressure &gt;30 mm Hg (48%) and left ventricular (LV) diastolic dysfunction (32%). Systolic dysfunction was observed in 2 (3,9%) subjects (Tables 2, 3).</p><p>Table 2</p><p>Results of echocardiography (n=51)</p><p>Abbreviations: LVMI — left ventricular mass index, EDV — end diastolic volume, EDD — end diastolic dimension, ESV — end systolic volume, LV — left ventricle, LA — left atrium, RA — right atrium, RV — right ventricle, EF — ejection fraction.</p><p>Table 3</p><p>Prevalence of echocardiographic abnormalities among centenarians (n=51)</p><p>Abbreviations: LV — left ventricle, LA — left atrium.</p><p>Ultrasound of carotid and femoral arteries. All long-livers had atherosclerotic plaques in the common carotid (CCA) and femoral arteries (mean, 5). However, hemodynamically significant stenoses (70% or more) were extremely rare: 3 and none in the CCA and femoral artery systems, respectively. The median intima-media thickness in the CCA system was approximately 1 mm, while in the femoral one — 1,5 mm (Table 4).</p><p>Table 4</p><p>Results of duplex ultrasound of main arteries (n=65)</p><p>Abbreviations: CFA — common femoral artery, CCA — common carotid artery, IMT — intima-media thickness.</p><p>Vascular stiffness. The vascular stiffness was determined in 67 centenarians, of which the median pulse wave velocity was 10 m/s, and the augmentation index was 31,3 (Table 5).</p><p>Table 5</p><p>Results of vascular stiffness examination (n=64)</p><p>Lipid profile. The lipid profile was analyzed in 65 study participants. According to formal criteria, dyslipidemia was found in 55%. Three patients continued to take statins (atorvastatin at a dose of 10-20 mg a day). An increase in TC &gt;5,0 mmol/L was in 55% (3,0-7,5 mmol/L), TG &gt;1,7 mmol/L — in 5,3% (0,6- 1,8 mmol/L), LDL &gt;3,0 mmol/L — in 44% (1,7-5,5 mmol/L), and a decrease in HDL &lt;1,0 mmol/L — in 43% (0,7-2,8 mmol/L) (Figure 3).</p><fig id="fig-3"/></sec><sec><title>Discussion</title><p>A healthy lifestyle, regular physical activity, healthy balanced diet, freedom from nicotine and alcohol products reduces the risk of CVD and cancer and, as a result, increases the duration of an active life in general.</p><p>Smoking (1,2%) and alcohol consumption (4,9%) are not very common among long-livers in Moscow. International data on this issue vary: in the Italian GEHA register, 3,2% of participants smoked [<xref ref-type="bibr" rid="cit7">7</xref>]; in the Chinese Dijiangyan Study — 43% [<xref ref-type="bibr" rid="cit8">8</xref>]. The same variability can be traced with regard to alcohol consumption: just over 50% of centenarians in Italy consumed 1 glass of wine per day throughout their lives, among Chinese centenarians — 27% (however, the volume and frequency of alcohol consumption is not indicated). It was typical for Moscow centenarians to drink alcoholic beverages on holidays and in a little amount (Social drinking).</p><p>Most of the patients led a sedentary lifestyle (68,3%) at the time of inclusion in the study, and 7,8% did exercise and 22% went for a walk regularly, but the majority of centenarians during the survey reported that they had an active lifestyle in youth and maturity. These results are inferior to the Italian GEHA data, where 37% did daily walking [<xref ref-type="bibr" rid="cit7">7</xref>], and the Chinese, where up to 40% did daily exercise [<xref ref-type="bibr" rid="cit8">8</xref>].</p><p>Overweight among young and middle-aged people is a well-known RF for CVD. Among older age people, BMI ceases to be such an unambiguous unfavorable factor. Recent studies have shown that among older patients, a low and normal BMI (&lt;23) is associated with higher mortality than those who had it in the range from 23 to 32 (which corresponds to overweight and even partially class 1 obesity) [<xref ref-type="bibr" rid="cit9">9</xref>]. Among the study participants, underweight and obesity were quite rare — 13,4% and 7,3%, respectively. There was no significant difference in BMI between survivors and deaths.</p><p>Severe dyslipidemia was not widespread among centenarians of Moscow and generally corresponded to the international data from Italy (TC, 5,2±1,2 mmol/L; LDL, 3,1±0,9 mmol /L) and China (TC, 4,2±0,8 mmol/L; LDL, 2,3±0,7 mmol/L) [7, 8].</p><p>A feature of centenarians is the late development of aging-associated diseases, including CVD [<xref ref-type="bibr" rid="cit10">10</xref>]. Among centenary veterans of the United States, the prevalence of hypertension was 45%, CAD — 20%, MI — 15% and HF — 32%) [<xref ref-type="bibr" rid="cit10">10</xref>]. The prevalence of hypertension and CAD was higher among Moscow centenarians, while the incidence of MI and HF was comparable.</p><p>In the literature there is little data on instrumental diagnostic tests of centenarians. Doppler ultrasound of the pulse wave of Okinawa long-livers demonstrated that, in general, the pulse wave velocity was &lt;10 m/s, which is typical for younger patients [<xref ref-type="bibr" rid="cit11">11</xref>] and correlates with the results of the Moscow study.</p><p>We have demonstrated the following patterns: LA dilation, increased LV mass, interventricular septal thickening, widespread pulmonary hypertension and diastolic dysfunction among the study participants.</p><p>All the data obtained correspond to the structural and functional cardiac abnormalities that occur with age. Thus, the Framingham study demonstrated that the prevalence of LA dilation increases with age and correlates with RFs for CVD [<xref ref-type="bibr" rid="cit12">12</xref>]. Another agingassociated change is LV diastolic dysfunction; its incidence doubles every decade starting at age 65 in men, and triples in women. In 2008, discrete upper septal thickening (DUST) was described for the first time [<xref ref-type="bibr" rid="cit13">13</xref>]. The prevalence of this phenomenon is directly proportional to age and, according to the Framingham study, reaches 18% among people over 85 years old. The question remains about the good quality of these changes and their impact on the human condition. There is evidence that hypertrophy of the interatrial septal basal part does not affect the normal rest function of a person, but can limit his physical activity, causing limitation of blood flow through the aortic valve [<xref ref-type="bibr" rid="cit13">13</xref>]. It has also been shown that the prevalence of diastolic dysfunction in different age groups varies and can reach 50% among healthy volunteers aged 65 and over [<xref ref-type="bibr" rid="cit14">14</xref>].</p><p>Despite the rather large number of atherosclerotic plaques in the common carotid and femoral arteries, the number of hemodynamically significant plaques was minimal. An intima-media thickening up to 1,0- 1,1 mm was found, which corresponds to the estimated age norm for centenarians [<xref ref-type="bibr" rid="cit15">15</xref>].</p><p>A study limitation is the design, which does not allow for clarification of causal relationships.</p></sec><sec><title>Conclusion</title><p>Over the past century, there has been a steady trend towards an increase in life expectancy. Longlivers in Moscow are characterized by a low prevalence of conventional RFs for CVD (with the exception of hypertension) and a fairly high prevalence of structural and functional cardiac and vascular abnormalities.</p></sec></body><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">GBD 2017 Mortality Collaborators. Global, regional, and national age-sex-specific mortality and life expectancy, 1950-2017: a systematic analysis for the Global Burden of Disease Study 2017 [published correction appears in Lancet. 2019;393(10190):e44]. Lancet. 2018;392(10159):1684-735. doi:10.1016/S0140-6736(18)31891-9.</mixed-citation><mixed-citation xml:lang="en">GBD 2017 Mortality Collaborators. Global, regional, and national age-sex-specific mortality and life expectancy, 1950-2017: a systematic analysis for the Global Burden of Disease Study 2017 [published correction appears in Lancet. 2019;393(10190):e44]. Lancet. 2018;392(10159):1684-735. doi:10.1016/S0140-6736(18)31891-9.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Robine JM, Cubaynes S. Worldwide demography of centenarians. Mechanism of Ageing and Development. 2017;165(В):56-97. doi:10.1016/j.mad.2017.03.004.</mixed-citation><mixed-citation xml:lang="en">Robine JM, Cubaynes S. Worldwide demography of centenarians. Mechanism of Ageing and Development. 2017;165(В):56-97. doi:10.1016/j.mad.2017.03.004.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Данные Росстата. Распределение населения по возрастным группам на январь 2019 года. https://gks.ru/search?q=rasnredeleniye+naseleniya+no+vozrastnym+gruppam.</mixed-citation><mixed-citation xml:lang="en">Russian official data about population. Data about amount of people by age (2019). (In Russ.) https://gks.ru/search?q=rasnredeleniye+naseleniya+no+vozrastnym+gruppam.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Garrow JS, Webster J. Quetelet's index (W/H2) as a measure of fatness. Int J Obes. 1985;9(2):147-53.</mixed-citation><mixed-citation xml:lang="en">Garrow JS, Webster J. Quetelet's index (W/H2) as a measure of fatness. Int J Obes. 1985;9(2):147-53.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001;285(19):2486-97. doi:10.1001/jama.285.19.2486.</mixed-citation><mixed-citation xml:lang="en">Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001;285(19):2486-97. doi:10.1001/jama.285.19.2486.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Lang RM, Bierig M, Devereux RB, et al. Recommendations for chamber quantification. Eur J Echocardiogr. 2006;7(2):79-108. doi:10.1016/j.euje.2005.12.014.</mixed-citation><mixed-citation xml:lang="en">Lang RM, Bierig M, Devereux RB, et al. Recommendations for chamber quantification. Eur J Echocardiogr. 2006;7(2):79-108. doi:10.1016/j.euje.2005.12.014.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Montesanto A, De Rango F, Pirazzini C, et al. Demographic, genetic and phenotypic characteristics of centenarians in Italy: Focus on gender differences. Mech Ageing Dev. 2017;165(Pt B):68-74. doi:10.1016/j.mad.2017.04.008.</mixed-citation><mixed-citation xml:lang="en">Montesanto A, De Rango F, Pirazzini C, et al. Demographic, genetic and phenotypic characteristics of centenarians in Italy: Focus on gender differences. Mech Ageing Dev. 2017;165(Pt B):68-74. doi:10.1016/j.mad.2017.04.008.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Zeng Y, Feng Q, Gu D, Vaupel JW. Demographics, phenotypic health characteristics and genetic analysis of centenarians in China. Mech Ageing Dev. 2017;165(Pt B):86-97. doi:10.1016/j.mad.2016.12.010.</mixed-citation><mixed-citation xml:lang="en">Zeng Y, Feng Q, Gu D, Vaupel JW. Demographics, phenotypic health characteristics and genetic analysis of centenarians in China. Mech Ageing Dev. 2017;165(Pt B):86-97. doi:10.1016/j.mad.2016.12.010.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Winter JE, MacInnis RJ, Wattanapenpaiboon N, Nowson CA. BMI and all-cause mortality in older adults: a meta-analysis. Am J Clin Nutr. 2014;99(4):875-90. doi:10.3945/ajcn.113.068122.</mixed-citation><mixed-citation xml:lang="en">Winter JE, MacInnis RJ, Wattanapenpaiboon N, Nowson CA. BMI and all-cause mortality in older adults: a meta-analysis. Am J Clin Nutr. 2014;99(4):875-90. doi:10.3945/ajcn.113.068122.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Selim AJ, Fincke G, Berlowitz DR, et al. Comprehensive health status assessment of centenarians: results from the 1999 large health survey of veteran enrollees. The Journals of gerontology. J Gerontol A Biol Sci Med Sci. 2005;60(4):515-9. doi:10.1093/gerona/60.4.515.</mixed-citation><mixed-citation xml:lang="en">Selim AJ, Fincke G, Berlowitz DR, et al. Comprehensive health status assessment of centenarians: results from the 1999 large health survey of veteran enrollees. The Journals of gerontology. J Gerontol A Biol Sci Med Sci. 2005;60(4):515-9. doi:10.1093/gerona/60.4.515.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Suzuki M, Wilcox BJ, Wilcox CD. Implications from and for food cultures for cardiovascular disease: longevity. Asia Pac J Clin Nutr. 2001;10(2):165-71. doi:10.1111/j.1440-6047.2001.00219.x.</mixed-citation><mixed-citation xml:lang="en">Suzuki M, Wilcox BJ, Wilcox CD. Implications from and for food cultures for cardiovascular disease: longevity. Asia Pac J Clin Nutr. 2001;10(2):165-71. doi:10.1111/j.1440-6047.2001.00219.x.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">McManus DD, Xanthakis V, Sullivan LM, et al. Longitudinal tracking of left atrial diameter over the adult life course: Clinical correlates in the community. Circulation. 2010;121(5):667-74. doi:10.1161/CIRCULATIONAHA.109.885806.</mixed-citation><mixed-citation xml:lang="en">McManus DD, Xanthakis V, Sullivan LM, et al. Longitudinal tracking of left atrial diameter over the adult life course: Clinical correlates in the community. Circulation. 2010;121(5):667-74. doi:10.1161/CIRCULATIONAHA.109.885806.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Pearson AC. The evolution of basal septal hypertrophy: From benign and age-related normal variant to potentially obstructive and symptomatic cardiomyopathy. Echocardiography. 2017;34(7):1062-72. doi:10.1111/echo.13588.</mixed-citation><mixed-citation xml:lang="en">Pearson AC. The evolution of basal septal hypertrophy: From benign and age-related normal variant to potentially obstructive and symptomatic cardiomyopathy. Echocardiography. 2017;34(7):1062-72. doi:10.1111/echo.13588.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Kuznetsova T, Herbots L, Lopez B, et al. Prevalence of left ventricular diastolic dysfunction in a general population. Circ Heart Fail. 2009;2(2):105-12. doi:10.1161/ CIRCHEARTFAILURE.108.822627.</mixed-citation><mixed-citation xml:lang="en">Kuznetsova T, Herbots L, Lopez B, et al. Prevalence of left ventricular diastolic dysfunction in a general population. Circ Heart Fail. 2009;2(2):105-12. doi:10.1161/CIRCHEARTFAILURE.108.822627.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Groenewegen K, den Ruijter H, Pasterkamp G, et al. Vascular age to determine cardiovascular disease risk: A systematic review of its concepts, definitions, and clinical applications. Eur J Prev Cardiol. 2015;23(3):264-74. doi:10.1177/2047487314566999.</mixed-citation><mixed-citation xml:lang="en">Groenewegen K, den Ruijter H, Pasterkamp G, et al. Vascular age to determine cardiovascular disease risk: A systematic review of its concepts, definitions, and clinical applications. Eur J Prev Cardiol. 2015;23(3):264-74. doi:10.1177/2047487314566999.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
